Clinical Trial Update: A Sickle CEll Disease ComplicatioN Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Micelle BioPharma Inc's investigational product for sickle cell disease; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Micelle BioPharma Inc investigational product

Snippet

Sponsor: Micelle BioPharma Inc | Conditions: Sickle Cell Disease | Phase 3 | Status: UNKNOWN